Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia

Introduction The aim of the study was to evaluate whether flow-mediated dilation (FMD) can be used to predict incident hypertension in patients with hyperuricemia. Material and methods Normotensive participants with and without hyperuricemia at baseline were prospectively enrolled. Flow-mediated di...

Full description

Bibliographic Details
Main Authors: Chunli Han, Zhanchao Xian, Yang Zou, Zhiyong Liao, Rongfeng Yang, Chunxia Zou, Xiaoqing Wang, Yan Sun
Format: Article
Language:English
Published: Termedia Publishing House 2019-03-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/Flow-mediated-dilation-can-be-used-to-predict-incident-hypertension-in-patients-with,81637,0,2.html
_version_ 1828975375261106176
author Chunli Han
Zhanchao Xian
Yang Zou
Zhiyong Liao
Rongfeng Yang
Chunxia Zou
Xiaoqing Wang
Yan Sun
author_facet Chunli Han
Zhanchao Xian
Yang Zou
Zhiyong Liao
Rongfeng Yang
Chunxia Zou
Xiaoqing Wang
Yan Sun
author_sort Chunli Han
collection DOAJ
description Introduction The aim of the study was to evaluate whether flow-mediated dilation (FMD) can be used to predict incident hypertension in patients with hyperuricemia. Material and methods Normotensive participants with and without hyperuricemia at baseline were prospectively enrolled. Flow-mediated dilation was assessed at baseline, and after 1 year’s follow-up the incidence of hypertension was compared between those with and without hyperuricemia. The predictive value of baseline FMD for incident hypertension among hyperuricemia patients was evaluated. Results A total of 222 participants were included. Mean systolic and diastolic blood pressure (BP) was 129.5 ±8.4 mm Hg and 78.3 ±7.9 mm Hg. Mean serum uric acid (UA) level was 4.4 ±2.8 mg/dl. Mean FMD was 5.1 ±2.7%. Compared to normal UA group, hyperuricemia group had higher proportion of male (58.4% vs. 61.2%), higher systolic BP (125.4 ±7.9 mm Hg vs. 132.1 ±7.3 mm Hg), serum high sensitivity C-reactive protein (3.9 ±2.2 mg/dl vs. 4.5 ±3.0 mg/dl) and UA (3.5 ±1.4 mg/dl vs. 5.7 ±0.7 mg/dl) levels, but lower mean FMD (5.6 ±2.4% vs. 4.8 ±2.0%) (p < 0.05 for all comparisons). No participant in normal UA group developed hypertension, while in hyperuricemia group, 6 participants developed hypertension. In hyperuricemia participants, after adjusted for covariates, per 1-standard deviation decrease in baseline FMD remained significantly associated with 15% increased risk of incident hypertension. Conclusions Patients with hyperuricemia have an increased risk of developing hypertension, and low baseline FMD in hyperuricemia patients is associated with significantly increased risk of incident hypertension.
first_indexed 2024-12-14T14:20:02Z
format Article
id doaj.art-c95fa6fb0ac2467e8b483cda965940bc
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-12-14T14:20:02Z
publishDate 2019-03-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-c95fa6fb0ac2467e8b483cda965940bc2022-12-21T22:58:07ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512019-03-0115234334910.5114/aoms.2018.7385681637Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemiaChunli Han0Zhanchao Xian1Yang Zou2Zhiyong Liao3Rongfeng Yang4Chunxia Zou5Xiaoqing Wang6Yan Sun7Department of Cardiology, the Fifth Subsidiary Sun Yat-sen University Hospital, Zhuhai, ChinaDepartment of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, ChinaDepartment of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, ChinaDepartment of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, ChinaDepartment of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, ChinaDepartment of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, ChinaDepartment of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, ChinaDepartment of Endocrinology, Xili People’s Hospital of Nanshan District, Shenzhen, ChinaIntroduction The aim of the study was to evaluate whether flow-mediated dilation (FMD) can be used to predict incident hypertension in patients with hyperuricemia. Material and methods Normotensive participants with and without hyperuricemia at baseline were prospectively enrolled. Flow-mediated dilation was assessed at baseline, and after 1 year’s follow-up the incidence of hypertension was compared between those with and without hyperuricemia. The predictive value of baseline FMD for incident hypertension among hyperuricemia patients was evaluated. Results A total of 222 participants were included. Mean systolic and diastolic blood pressure (BP) was 129.5 ±8.4 mm Hg and 78.3 ±7.9 mm Hg. Mean serum uric acid (UA) level was 4.4 ±2.8 mg/dl. Mean FMD was 5.1 ±2.7%. Compared to normal UA group, hyperuricemia group had higher proportion of male (58.4% vs. 61.2%), higher systolic BP (125.4 ±7.9 mm Hg vs. 132.1 ±7.3 mm Hg), serum high sensitivity C-reactive protein (3.9 ±2.2 mg/dl vs. 4.5 ±3.0 mg/dl) and UA (3.5 ±1.4 mg/dl vs. 5.7 ±0.7 mg/dl) levels, but lower mean FMD (5.6 ±2.4% vs. 4.8 ±2.0%) (p < 0.05 for all comparisons). No participant in normal UA group developed hypertension, while in hyperuricemia group, 6 participants developed hypertension. In hyperuricemia participants, after adjusted for covariates, per 1-standard deviation decrease in baseline FMD remained significantly associated with 15% increased risk of incident hypertension. Conclusions Patients with hyperuricemia have an increased risk of developing hypertension, and low baseline FMD in hyperuricemia patients is associated with significantly increased risk of incident hypertension.https://www.archivesofmedicalscience.com/Flow-mediated-dilation-can-be-used-to-predict-incident-hypertension-in-patients-with,81637,0,2.htmlhypertensionflow-mediated dilationhyperuricemia
spellingShingle Chunli Han
Zhanchao Xian
Yang Zou
Zhiyong Liao
Rongfeng Yang
Chunxia Zou
Xiaoqing Wang
Yan Sun
Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
Archives of Medical Science
hypertension
flow-mediated dilation
hyperuricemia
title Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
title_full Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
title_fullStr Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
title_full_unstemmed Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
title_short Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
title_sort flow mediated dilation can be used to predict incident hypertension in patients with hyperuricemia
topic hypertension
flow-mediated dilation
hyperuricemia
url https://www.archivesofmedicalscience.com/Flow-mediated-dilation-can-be-used-to-predict-incident-hypertension-in-patients-with,81637,0,2.html
work_keys_str_mv AT chunlihan flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT zhanchaoxian flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT yangzou flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT zhiyongliao flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT rongfengyang flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT chunxiazou flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT xiaoqingwang flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia
AT yansun flowmediateddilationcanbeusedtopredictincidenthypertensioninpatientswithhyperuricemia